Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 ILa | 0.00% | -3.57% | +3.85% |
May. 12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
May. 09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- CANF Stock
- Revisions Can-Fite BioPharma Ltd.